MetaVia Inc. (MTVA) intrinsic value & 10-year financials

MetaVia Inc. (MTVA) has no Graham intrinsic value right now because the formula needs positive earnings.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$1.26
Market cap
$2.2M
Revenue (FY2025)
—
ROIC (10-yr avg)
468.0%
Free cash flow (FY2025)
-$15.7M

MTVA 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 — -$13.0M -$7.35 -$15.7M — 213.7%
FY2024 — -$27.6M -$3.56 -$24.7M — 422.4%
FY2023 — -$12.5M -$2.46 -$10.8M — 283.0%
FY2022 — -$14.0M -$2.71 — — 1124.8%
FY2021 — -$15.3M -$0.33 -$15.1M — 670.8%
FY2020 — -$29.7M -$0.92 -$10.8M — 1370.0%
FY2019 — -$21.3M — -$7.3M — 1325.6%
FY2018 — -$23.6M — -$21.9M — -389.3%
FY2017 — -$33.4M — — — -269.6%
FY2016 — -$14.6M — — — -71.2%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

MetaVia Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

MetaVia Inc. has historically struggled to out-earn its cost of capital, averaging just -2.4% ROIC.

MetaVia Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

MetaVia Inc. is evaluated under Benjamin Graham's defensive framework using SEC EDGAR fundamentals using an 8.5 + 2g earnings multiple and a 5.1% AAA bond-yield baseline.

MTVA stock: frequently asked questions

What is the intrinsic value of MetaVia Inc. (MTVA) stock?

Graham's formula only works with positive earnings. MetaVia Inc. reported diluted EPS of -$7.35 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

Does MetaVia Inc. generate free cash flow?

MetaVia Inc. generated -$15.7M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 0 of the last 7 reported years.

What is MTVA's return on invested capital?

Average ROIC over the last 10 fiscal years was 468.0%, and average return on equity was -196.5%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this MTVA data come from?

From MetaVia Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 14, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar pharmaceutical preparations stocks